5-Aza-2′-deoxycytidine Leads to Reduced Embryo Implantation and Reduced Expression of DNA Methyltransferases and Essential Endometrial Genes

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Ding, Yu Bin ^a   Long, Chun Lan ^a   Liu, Xue Qing ^a   Chen, Xue Mei ^a   Guo, Liang Rui ^a   Xia, Yin Yin ^a   He, Jun Lin ^a   Wang, Ying Xiong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR HOXA10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXICITY; DECIDUALIZATION; DNA FLANKING REGION; DNA METHYLATION; DOWN REGULATION; EMBRYO TRANSFER; ESTROGEN RECEPTOR ALPHA GENE; FEMALE; GENE EXPRESSION REGULATION; HOMEOBOX A10 GENE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NIDATION; NONHUMAN; PROGESTERONE RECEPTOR GENE; PROTEIN EXPRESSION; REDUCTION KINETICS; STROMA CELL; WESTERN BLOTTING;

ANIMALS; AZACITIDINE; BLOTTING, WESTERN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EMBRYO IMPLANTATION; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; PREGNANCY; RECEPTORS, PROGESTERONE;

MUS;

EID: 84866975039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045364     Document Type: Article

References (55)

1. Juttermann R, Li E, Jaenisch R, (1994) Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci U S A 91: 11797-11801.
2. Schmahl W, Torok P, Kriegel H, (1984) Embryotoxicity of 5-azacytidine in mice. Phase- and dose-specificity studies. Arch Toxicol 55: 143-147.
3. Rosen MB, Chernoff N, (2002) 5-Aza-2′-deoxycytidine-induced cytotoxicity and limb reduction defects in the mouse. Teratology 65: 180-190.
4. Cisneros FJ, Branch S, (2003) 5-AZA-2′-deoxycytidine (5-AZA-CdR): a demethylating agent affecting development and reproductive capacity. J Appl Toxicol 23: 115-120.
5. Oka M, Meacham AM, Hamazaki T, Rodic N, Chang LJ, et al. (2005) De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene 24: 3091-3099.
6. Jung Y, Park J, Kim TY, Park JH, Jong HS, et al. (2007) Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. J Mol Med (Berl) 85: 1137-1148.
7. Ghoshal K, Datta J, Majumder S, Bai S, Kutay H, et al. (2005) 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol Cell Biol 25: 4727-4741.
8. Deng T, Zhang Y, (2009) 5-Aza-2′-deoxycytidine reactivates expression of RUNX3 by deletion of DNA methyltransferases leading to caspase independent apoptosis in colorectal cancer Lovo cells. Biomed Pharmacother 63: 492-500.
9. Yu JN, Xue CY, Wang XG, Lin F, Liu CY, et al. (2009) 5-AZA-2′-deoxycytidine (5-AZA-CdR) leads to down-regulation of Dnmt1o and gene expression in preimplantation mouse embryos. Zygote 17: 137-145.
10. Ding L, Qiu L, Zhang J, Guo B, (2009) Camptothecin-induced cell proliferation inhibition and apoptosis enhanced by DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine. Biol Pharm Bull 32: 1105-1108.
11. Qiu YY, Mirkin BL, Dwivedi RS, (2002) Differential expression of DNA-methyltransferases in drug resistant murine neuroblastoma cells. Cancer Detect Prev 26: 444-453.
12. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP, (2007) Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 115: 1454-1459.
13. Ando T, Nishimura M, Oka Y, (2000) Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells. Leukemia 14: 1915-1920.
14. Gius D, Cui H, Bradbury CM, Cook J, Smart DK, et al. (2004) Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6: 361-371.
15. Schmelz K, Sattler N, Wagner M, Lubbert M, Dorken B, et al. (2005) Induction of gene expression by 5-Aza-2′-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and-independent mechanisms. Leukemia 19: 103-111.
16. Yap OW, Bhat G, Liu L, Tollefsbol TO, (2009) Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. Anticancer Res 29: 139-144.
17. Arai M, Yokosuka O, Hirasawa Y, Fukai K, Chiba T, et al. (2006) Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-Aza-2′-deoxycytidine. Cancer 106: 2514-2525.
18. Yamagata Y, Asada H, Tamura I, Lee L, Maekawa R, et al. (2009) DNA methyltransferase expression in the human endometrium: down-regulation by progesterone and estrogen. Hum Reprod 24: 1126-1132.
19. Vincent ZL, Farquhar CM, Mitchell MD, Ponnampalam AP (2011) Expression and regulation of DNA methyltransferases in human endometrium. Fertil Steril 95: 1522-1525 e1521.
20. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, et al. (2007) Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77: 681-687.
21. Wu H, Chen Y, Liang J, Shi B, Wu G, et al. (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438: 981-987.
22. Rahnama F, Thompson B, Steiner M, Shafiei F, Lobie PE, et al. (2009) Epigenetic regulation of E-cadherin controls endometrial receptivity. Endocrinology 150: 1466-1472.
23. Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr, et al. (2007) Hypomethylation-induced expression of S100A4 in endometrial carcinoma. Mod Pathol 20: 1045-1054.
24. Trundley AE, Hiby SE, Chang C, Sharkey AM, Santourlidis S, et al. (2006) Molecular characterization of KIR3DL3. Immunogenetics 57: 904-916.
25. Logan PC, Ponnampalam AP, Rahnama F, Lobie PE, Mitchell MD, (2010) The effect of DNA methylation inhibitor 5-Aza-2′-deoxycytidine on human endometrial stromal cells. Hum Reprod 25: 2859-2869.
26. Tan J, Paria BC, Dey SK, Das SK, (1999) Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology 140: 5310-5321.
27. Ramathal CY, Bagchi IC, Taylor RN, Bagchi MK, (2010) Endometrial decidualization: of mice and men. Semin Reprod Med 28: 17-26.
28. Taylor HS, Arici A, Olive D, Igarashi P, (1998) HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 101: 1379-1384.
29. Finn CA, Martin L, (1972) Endocrine control of the timing of endometrial sensitivity to a decidual stimulus. Biol Reprod 7: 82-86.
30. Branch S, Francis BM, Brownie CF, Chernoff N, (1996) Teratogenic effects of the demethylating agent 5-aza-2′-deoxycytidine in the Swiss Webster mouse. Toxicology 112: 37-43.
31. Sun X, Zhang L, Xie H, Wan H, Magella B, et al. (2012) Kruppel-like factor 5 (KLF5) is critical for conferring uterine receptivity to implantation. Proc Natl Acad Sci U S A 109: 1145-1150.
32. Ding YB, He JL, Liu XQ, Chen XM, Long CL, et al. (2012) Expression of DNA methyltransferases in the mouse uterus during early pregnancy and susceptibility to dietary folate deficiency. Reproduction: in press.
33. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, et al. (1996) Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122: 2687-2696.
34. Lim H, Ma L, Ma WG, Maas RL, Dey SK, (1999) Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol Endocrinol 13: 1005-1017.
35. Zhu LJ, Cullinan-Bove K, Polihronis M, Bagchi MK, Bagchi IC, (1998) Calcitonin is a progesterone-regulated marker that forecasts the receptive state of endometrium during implantation. Endocrinology 139: 3923-3934.
36. Lessey BA, Palomino WA, Apparao KB, Young SL, Lininger RA, (2006) Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol 4 (Suppl 1): S9.
37. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM, (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289: 1751-1754.
38. Iwase H, Omoto Y, Iwata H, Toyama T, Hara Y, et al. (1999) DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br J Cancer 80: 1982-1986.
39. Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, et al. (2006) Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer 107: 299-308.
40. Shen R, Tao L, Xu Y, Chang S, Van Brocklyn J, et al. (2009) Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer. Int J Clin Exp Pathol 2: 21-33.
41. Wu Y, Starzinski-Powitz A, Guo SW, (2008) Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril 90: 234-237.
42. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, et al. (2007) Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81: 280-287.
43. Hill VK, Ricketts C, Bieche I, Vacher S, Gentle D, et al. (2011) Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity. Cancer Res 71: 2988-2999.
44. Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, et al. (2008) DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 68: 210-222.
45. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW, (2006) Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1: 106-111.
46. Lu Y, Nie J, Liu X, Guo SW, (2010) Reduced expression and concomitant promoter hypermethylation of HOXA10 in endometrium from women wearing intrauterine devices. Fertil Steril 94: 1583-1588.
47. Cheng W, Jiang Y, Liu C, Shen O, Tang W, et al. (2010) Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer. J Cancer Res Clin Oncol 136: 1221-1227.
48. Wu Y, Halverson G, Basir Z, Strawn E, Yan P, et al. (2005) Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193: 371-380.
49. Bromer JG, Wu J, Zhou Y, Taylor HS, (2009) Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming. Endocrinology 150: 3376-3382.
50. Chai G, Li L, Zhou W, Wu L, Zhao Y, et al. (2008) HDAC inhibitors act with 5-aza-2′-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS ONE 3: e2445.
51. Pryzbylkowski P, Obajimi O, Keen JC, (2008) Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. Breast Cancer Res Treat 111: 15-25.
52. Sampath D, Rao VA, Plunkett W, (2003) Mechanisms of apoptosis induction by nucleoside analogs. Oncogene 22: 9063-9074.
53. Graham FL, Whitmore GF, (1970) Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5′-triphosphate. Cancer Res 30: 2636-2644.
54. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, et al. (1997) Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem 272: 32260-32266.
55. Kuo HK, Griffith JD, Kreuzer KN, (2007) 5-Azacytidine induced methyltransferase-DNA adducts block DNA replication in vivo. Cancer Res 67: 8248-8254.